Get the Stockscreener App
3.38
4.79%
-0.17
After Hours:
3.20
-0.18
-5.33%
Allurion Technologies Inc stock is traded at $3.38, with a volume of 172.17K.
It is down -4.79% in the last 24 hours and down -61.10% over the past month.
Allurion Technologies Inc is a medical device company that focuses on creating a best-in-class weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.
See More
Previous Close:
$3.55
Open:
$3.42
24h Volume:
172.17K
Relative Volume:
0.13
Market Cap:
$16.20M
Revenue:
$34.75M
Net Income/Loss:
$-24.76M
P/E Ratio:
-0.2817
EPS:
-12
Net Cash Flow:
$-50.91M
1W Performance:
-34.37%
1M Performance:
-61.10%
6M Performance:
-80.19%
1Y Performance:
-95.26%
1-Day Range:
$3.10
$3.5068
1-Week Range:
$3.10
$5.78
52-Week Range:
$2.3669
$98.75
Allurion Technologies Inc Stock (ALUR) Company Profile
Name
Allurion Technologies Inc
Sector
Industry
Phone
508-647-4000
Address
11 HURON DR STE 200, NATICK
Compare ALUR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ALUR
Allurion Technologies Inc
|
3.38 | 16.20M | 34.75M | -24.76M | -50.91M | -12.00 |
|
ABT
Abbott Laboratories
|
134.95 | 234.06B | 41.95B | 13.40B | 6.49B | 7.65 |
|
BSX
Boston Scientific Corp
|
104.39 | 154.06B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
387.92 | 148.02B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
90.17 | 115.71B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
72.76 | 42.91B | 5.72B | 4.17B | 490.10M | 6.97 |
Allurion Technologies Inc Stock (ALUR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-14-24 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| Oct-02-24 | Initiated | TD Cowen | Buy |
| Sep-06-24 | Initiated | ROTH MKM | Buy |
| Feb-09-24 | Initiated | Jefferies | Buy |
Allurion Technologies Inc Stock (ALUR) Latest News
Allurion to raise $6.1 million in direct offering and private placement - MSN
Allurion Announces Closing of Offering and Concurrent Private Placement to Advance GLP-1 Clinical Pipeline - Business Wire
Allurion announces $6.1 million stock and warrant sale - Investing.com
Allurion Tech dips on $6.1 million stock offering - TradingView
S&P 500 Edges Higher; Analog Devices Earnings Top Views - Benzinga
Allurion Technologies Expects to Raise $6.1 Million From Stock Offering; Shares Plunge - Marketscreener.com
Dow Dips 150 Points; US Housing Starts Fall In January - Benzinga
Allurion to sell 900,000 shares at $5.23 in registered direct offering - TipRanks
Allurion announces $6.1 million stock and warrant sale By Investing.com - Investing.com UK
Allurion to Raise Approximately $6.1 Million of Gross Proceeds in Offering and Concurrent Private Placement to Advance GLP-1 Clinical Pipeline - Business Wire
Allurion Announces Plans To Combine GLP-1 Therapy With The Allurion Balloon to Treat Obesity - BioSpace
Allurion stock soars 70% on weight-loss therapy update - MSN
Allurion to study balloon and GLP-1 therapy combo - Investing.com
Allurion to study balloon and GLP-1 therapy combo By Investing.com - Investing.com South Africa
Allurion Technologies to initiate Allurion Balloon with GLP-1 agonists study - TipRanks
Allurion cleared to resume sale of swallowable gastric balloon in France - BioWorld Online
ALURAllurion Relaunches in France - ADVFN Logo
Allurion Technologies relaunches in France - TipRanks
ANSM Clears Allurion To Resume Sales Of Allurion Balloon -February 13, 2025 at 08:40 am EST - Marketscreener.com
Allurion Relaunches in France - Business Wire
Allurion Technologies Touts Positive Study Results for its Weight Loss Balloon - MPO-mag
How Much Upside is Left in Allurion Technologies, Inc. (ALUR)? Wall Street Analysts Think 374.67% - MSN
Allurion announces study on obesity treatment enhancement - MSN
12 Consumer Discretionary Stocks Moving In Tuesday's Pre-Market Session - Benzinga
This Little-Known Stock Just Doubled on Weight-Loss Drug News. Analysts Think It Has 400% Upside Potential From Here. - MSN
Eli Lilly and Company (LLY-N) QuotePress Release - The Globe and Mail
11 Consumer Discretionary Stocks Moving In Monday's Pre-Market Session - Benzinga
Allurion Technologies Soars 200% Amid Stock Offering and New Clinical Study Plans for Weight Loss Product - HPBL
Allurion Technologies Shares Surge as Company Eyes Obesity Drug Market with Gastric Balloon-GLP-1 Combo - HPBL
Why Logility Supply Chain Solutions Shares Are Trading Higher By Over 23%; Here Are 20 Stocks Moving Premarket - Benzinga
Allurion extends rally despite $7.4M stock and warrants offering - MSN
Allurion Soared Over 200% Today, But Is The Weight-Loss Stock A Buy? - Barchart
Allurion Catapults 200% On Its Plans To Outdo Eli Lilly, Novo Nordisk - MSN
Allurion Catapults 132% On Its Plans To Outdo Eli Lilly, Novo Nordisk - Yahoo! Voices
Allurion Technologies Shares Are Up Today: What's Going On? - Benzinga
Allurion Stock Triples on Plan to Test Gastric Balloon With Obesity Drugs - MSN
Allurion shares soar 77% after sharing plans for GLP-1RA combo trial - Yahoo Finance
Allurion Technologies Launches Stock Offering To Boost Growth - Evrim Ağacı
Allurion Technologies stock soars on clinical study announcement - MSN
Dow Falls 100 Points; US Manufacturing PMI Rises In January - Benzinga
Allurion Stock Explodes Following Clinical Study Announcement - Wall Street Pit
Allurion Shares Surge 185% Following $7.4 Million Fundraising Announcement - Yahoo Finance
Investors Are Buzzing! Major Breakthrough in Weight Loss Technology! - Jomfruland.net
Allurion Stock Skyrockets 80% After Hours Following Clinical Study Announcement - Yahoo Finance
Allurion Technologies' Stock Soars After Clinical Study Announcement - Evrim Ağacı
US Stocks Mixed; Verizon Posts Upbeat Sales - Benzinga
Allurion Technologies to sell 1.24M shares at $6 in registered direct offering - TipRanks
Allurion to Raise Approximately $7.4 Million of Gross Proceeds in Offering Priced At-the-Market - The Bakersfield Californian
Allurion Technologies Inc Stock (ALUR) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.10%
0.57%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):